Compile Data Set for Download or QSAR
maximum 50k data
Found 16 Enz. Inhib. hit(s) with all data for entry = 10102
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513990(US11059830, Compound 1)
Affinity DataKd:  355nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513996((2S)-1-((4R,7S)-7-((2R,3S,4R,11 S,12R)-12-benzyl-3...)
Affinity DataKd:  21.5nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513993(US11059830, Compound 3)
Affinity DataKd:  0.340nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513994(US11059830, Compound 4)
Affinity DataKd:  4.80nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513995(US11059830, Compound 5)
Affinity DataKd:  18.8nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513996((2S)-1-((4R,7S)-7-((2R,3S,4R,11 S,12R)-12-benzyl-3...)
Affinity DataKd:  0.510nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513997(US11059830, Compound 7)
Affinity DataKd:  0.950nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513998(US11059830, Compound 8)
Affinity DataKd:  1.10nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513999(US11059830, Compound 9)
Affinity DataKd:  785nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM514000((S)-1-(2-((2R,3R,6S)-6-((2R,3R,4S,6E,9E,11R,12R)-1...)
Affinity DataKd:  0.210nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513990(US11059830, Compound 1)
Affinity DataKd:  71.5nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513992(US11059830, Compound 2)
Affinity DataKd:  12.6nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513993(US11059830, Compound 3)
Affinity DataKd:  1.30nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513994(US11059830, Compound 4)
Affinity DataKd:  23.1nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513995(US11059830, Compound 5)
Affinity DataKd:  7nMAssay Description:This protocol utilizes Surface Plasmon Resonance (SPR) as a method to determine kinetics (KD, Ka, Kd) for the binding of compound (analyte) to immobi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPeptidyl-prolyl cis-trans isomerase FKBP1A(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM513992(US11059830, Compound 2)
Affinity DataKd:  1.5nMAssay Description:The binding of compounds of the invention to FKBP12 can be determined using the following protocol.General ProtocolThis protocol utilizes Perkin Elme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent